Measuring gelatinase activity in colorectal cancer

European Journal of Surgical Oncology

Volumn 28, Issue 1, 2002, Pages 24-29

  Baker, E A ^a   Leaper, D J ^a  

^a UNIVERSITY HOSPITAL OF NORTH TEES   (United Kingdom)

Author keywords

Colorectal cancer; Gelatinases; Matrix metalloproteinases; Metastasis

Indexed keywords

GELATINASE; GELATINASE A; GELATINASE B;

ARTICLE; CANCER STAGING; COLORECTAL ADENOMA; COLORECTAL CANCER; CONTROLLED STUDY; ENZYME ACTIVITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; ZYMOGRAPHY; COLORECTAL TUMOR; ENZYMOLOGY; LYMPH NODE METASTASIS; METABOLISM; METASTASIS; PATHOLOGY;

COLORECTAL NEOPLASMS; GELATINASES; HUMANS; LYMPHATIC METASTASIS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM METASTASIS;

EID: 0036484458     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejso.2001.1179     Document Type: Article

References (19)

1. Liotta LA, Stetler-Stevenson WG. Metalloproteinases and cancer invasion. Sem Cancer Biol 1990; 1: 99-106.
2. Matrisian LM. Metalloproteinases and their inhibitors in matrix remodelling. Trends in Genetics 1990; 6: 121-5.
3. Cottam DW, Rees RC. Regulation of matrix metalloproteinases: their role in tumour invasion and metastasis. Int J Oncol 1993; 2: 861-72.
4. Ennis BW, Matrisian LM. Matrix degrading metalloproteinases. J Neuro Oncol 1994; 18: 105-9.
5. Liabakk NB, Talbot I, Smith RA, Wilkinson K, Balkwill F. Matrix metalloproteinase-2 (MMP-2) and matrix metalloproteinase-9 (MMP-9) type IV collagenases in colorectal cancer. Cancer Res 1996; 56: 190-6.
6. Parsons SL, Watson SA, Collins HM, Griffin NR, Clarke PA, Steele RJC. Gelatinase (MMP-2 and -9) expression in gastrointestinal malignancy. Br J Cancer 1998; 78: 1495-1502.
7. Garbett EA, Reed MWR, Brown NJ. Proteolysis in colorectal cancer. J Clin Pathol: Mol Pathol 1999; 52: 140-5.
8. Zeng ZS, Cohen AM, Guillem JG. Loss of basement membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during human colorectal tumorigenesis. Carcinogenesis 1999; 20: 749-55.
9. Zucker S, Lysik RM, Zarrabi MH, Moll U. Mr 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer. Cancer Res 1993; 53: 140-6.
10. Oberg A, Hoyhtya M, Tavelin B, Stenling R, Lindmark G. Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer. Anticancer Res 2000; 20: 1085-92.
11. Gallegos NC, Smales C, Savage FJ, Hembry RM, Boulos PB. The distribution of matrix metalloproteinases and tissue inhibitors of metalloproteinases in colorectal cancer. Surg Oncol 1995; 4: 111-9.
12. Poulsom R, Pignatelli M, Stetler-Stevenson WG, Liotta LA, Wright PA, Jeffrey RE, et al. Stromal expression of 72 kDa type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia. Am] Pathol 1992; 141: 389-96.
13. Zeng ZS, Guillem JG. Distinct patterns of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase-1 mRNA expression in colorectal cancer and liver metastases. Br J Cancer 1995; 72: 575-82.
14. Ohnishi ST, Barr JK. A simplified method of quantifying proteins using the biuret and phenol reagents. Anal Biochem 1978; 86: 193-200.
15. Heussen C, Dowdle E. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulphate and copolymerised substrates. Anal Biochem 1980; 102: 196-202.
16. Levy AT, Cioce V, Sobel ME, et al. Increased expression of the Mr 72,000 type IV collagenase in human colonic adenocarcinoma. Cancer Res 1991; 51: 439-44.
17. Ring P, Johansson K, Hoyhtya M, Rubin K, Lindmark G. Expression of tissue inhibitor of metalloproteinases TIMP-2 in human colorectal cancer - a predictor of tumour stage. Br J Cancer 1997; 76: 805-811.
18. Kikuchi R, Noguchi T, Kubo N, Uchida Y. Immunohistochemical detection of membrane-type-1 matrix metalloproteinase in colorectal carcinoma. Br J Cancer 2000; 83: 215-8.
19. Mukai M, Sadahiro S, Tokunaga N, et al. The expression of MMP-2 and TIMP-2 in patients with primary colorectal adenocarcinomas: correlation with liver metastasis. Oncol Reports 1999; 6: 969-73.